Introduction
Influenza A virus (IAV) is a respiratory pathogen responsible for seasonal epidemics that can cause severe disease and death, most commonly in the very young, very old, and immunocompromised individuals in the population (1) . Vaccination strategies have traditionally prioritized antibody responses, but there is increasing evidence that IAV-specific T cells confer heterosubtypic protection that correlates with reduced symptom severity during infection (2, 3) . During a primary IAV infection, CD8 + T cells are critical for viral clearance, which they accomplish by directly killing infected cells through death receptor interactions and perforin and granzyme (4, 5) . IAV-specific CD4 + T cells provide help to both the CD8 + T cell and B cell responses and support the antiviral functions of innate immune cells through production of IFN-γ (6) . IAV-specific Th1 cells comprise the majority of the IAV-specific CD4 + T cell response, including the recently described cytotoxic CD4 + T cells that directly kill IAV-infected cells (7) . IAV-specific Tregs are also present and help to restrain tissue damage caused by exaggerated nonspecific innate immune responses and targeted cytotoxic CD8 + T cell-mediated killing of infected cells (8) (9) (10) (11) .
Antigen-presenting cells (APCs) at the site of infection are indispensable for regulating the magnitude and character of T cell responses in diverse inflammatory contexts (12) . Depletion of phagocytic cells in the lungs following IAV infection results in premature apoptosis of IAV-specific T cells, due to the loss of critical survival signals normally provided by dendritic cells (DCs) (13, 14) . DC interactions with T cells can also result in T cell death, which is exemplified by enhanced killing of IAV-specific CD8 + T cells by plasmacytoid DCs in the lung draining lymph nodes (dLNs) during lethal IAV infection (15) (16) (17) . Induction of the appropriate phenotype in DCs depends on receipt of proinflammatory signals through cytokine and chemokine receptors and pattern recognition receptors (PRRs).
NLRC4 is an intracellular PRR belonging to the nucleotide oligomerization and binding domain and leucine-rich repeatcontaining (NLR) family. NLRC4 is best described for its role as part of the multiprotein inflammasome complex that mediates processing and secretion of IL-1β and IL-18 and induces a pyroptotic cell death (18) . The NLRC4 inflammasome is activated in response to infection with Gram-negative bacteria, and the resultant IL-18 production in CD8α + DCs during infection is important for memory CD8 + T cell activation in this context (19) . In a syngeneic subcutaneous melanoma model, NLRC4-deficient mice were reported to have defective intratumoral CD4 + and CD8 + T cell responses and increased tumor burdens (20) . Considering the importance of T cell responses in viral infection and the evidence supporting a role for NLRC4 in direct or indirect modulation of T cell responses in these different settings, we assessed the role of NLRC4 in the host response to IAV infection. We report Influenza A virus-specific (IAV-specific) T cell responses are important correlates of protection during primary and subsequent infections. The generation and maintenance of robust IAV-specific T cell responses relies on T cell interactions with dendritic cells (DCs) . In this study, we explore the role of the nucleotide-binding domain leucine-rich repeatcontaining receptor family member NLRC4 in modulating the DC phenotype during IAV infection. Nlrc4 -/-mice had worsened survival and increased viral titers during infection, normal innate immune cell recruitment, and IAV-specific CD8 + T cell responses, but severely blunted IAV-specific CD4 + T cell responses compared with WT mice. The defect in the pulmonary IAV-specific CD4 + T cell response was not a result of defective priming or migration of these cells in Nlrc4 Figure 1C ). The susceptibility of Nlrc4 -/-mice to IAV was dose dependent, and infection with a 0.25 median lethal dose (LD 50 ) inoculum of IAV resulted in similar mortality rates between WT and Nlrc4 -/-mice ( Figure 1D ). Consistent with previous studies, Asc -/-mice had increased mortality compared with WT mice ( Figure 1D ) (21, 22) .
NLRC4 is best known for its role as part of the NLRC4 inflammasome, which is formed upon recognition of bacterial flagellin and components of the type III secretion system by NAIP proteins (23, 24) . Activation of the NLRC4 inflammasome results in cleavage of pro-caspase-1 into its active form, which in turn cleaves pro-IL-1β and pro-IL-18 into their mature secreted forms. Formation of the NLRC4 inflammasome within the lungs seemed unlikely in the context of a viral infection, and, indeed, we detected no defect in cleavage of pro-caspase-1 in lung homogenates from Nlrc4 -/-mice 24 hours after infection with IAV ( Figure  1E ). These data suggest an inflammasome-independent role for NLRC4 in the control of IAV infection in vivo. 
Results

Nlrc4
-/-mice have increased morbidity and mortality during IAV infection. To determine the effect of NLRC4 deficiency on outcome during IAV infection, we compared the morbidity and mortality of WT and Nlrc4 -/-mice following infection with IAV. We observed significantly increased morbidity and mortality among expressed on antigen-experienced cells and, in the context of IAV infection, reflect the cells that have been exposed to IAV-specific antigen (31) . We detected a significant decrease in the total and IAV-specific CD4 + T cell response in the lungs of Nlrc4 -/-mice compared with responses in WT mice on day 7 after infection ( Figure 2, A and B) . Interestingly, the decrease in IAV-specific CD4 + T cells in Nlrc4 -/-mice was not present on day 3 or day 5 after infection in the lungs, dLNs, or spleen ( The IAV-specific CD4 + T cell response is predominantly a Th1-polarized response with a smaller number of IAV-specific Tregs, which are protective during a primary infection (7, 32, 33) . Consistent with the significantly decreased number of total IAV-specific CD4 + T cells in Nlrc4 -/-mice, we found significant decreases in IAV-specific Th1 (Tbet The IAV-specific CD8 + T cell response is crucial for viral clearance during a primary IAV infection, thus we quantified this response in WT and Nlrc4 -/-mice (34). We detected small decreases in the frequency and number of total lung CD8 + T
-/-mice have intact production of inflammatory mediators and innate immune cells in the lungs. Excessive inflammation is a well-documented cause of pathology during IAV infection (25, 26) . Given the increased IAV-induced mortality seen among Nlrc4 -/-mice, we compared the production of inflammatory mediators in the lungs of WT and Nlrc4 -/-mice following IAV infection and found no significant differences (Supplemental Figure 1 ; supplemental material available online with this article; https://doi. org/10.1172/JCI124937DS1). Consistent with the similarity in the levels of innate cell chemoattractants in WT and Nlrc4 -/-mice, the number of lung-infiltrating and lung-resident inflammatory cells was similar in WT and Nlrc4 -/-mice on days 3 and 5 after infection ( Figure 1 , F-J).
Defective pulmonary IAV-specific T cell responses in Nlrc4 -/-mice. The IAV-specific CD4 + T cell response occurs primarily within the lungs and comprises a wide variety of specificities, with a relatively small proportion of the cells being specific for each antigen (27) (28) (29) . While useful for the immune response, this breadth of specificities complicates measurement of the total response as the sum of all the individual antigen-specific responses. Hence, we quantified the total IAV-specific CD4 + T cell response using the surrogate markers CD49d and CD11a (30), which are highly Figure 2F ).
Together, these data reveal a defect in the pulmonary IAVspecific CD4 + T cell response in Nlrc4 -/-mice. IAV-specific CD4 + T cell responses are important for successful viral clearance and recovery from IAV infection (32, 35) , thus these defects probably contribute to the enhanced mortality evident in Nlrc4 -/-mice.
DC and T cell accumulation in lung dLNs is intact in Nlrc4
-/-mice. To identify the cause of the blunted IAV-specific CD4 + T cell response, we evaluated key steps in the generation of this response. Initiation of robust IAV-specific T cell responses relies on successful interactions in the secondary lymphoid organs with antigen-bearing APCs, many of which have migrated from the lungs (6) . Accelerated respiratory DC migration to the lung dLNs lasts for about 48 hours after IAV infection (36) . Twenty-four hours after infection, we noted no significant difference in the proportion of CD11c + cells originating from the lungs in the lung dLNs of WT or Nlrc4 -/-mice (Supplemental Figure 3 , A and B), indicating that defective DC migration was not likely to be contributing to the blunted IAV-specific CD4 + T cell response in Nlrc4 -/-mice. Further characterization of the DC phenotype in lung dLNs revealed no differences in the abundance or expression of costimulatory molecules on DCs in WT or Nlrc4 -/-mice (Supplemental Figure 3 , C-H). These findings are consistent with the normal accumulation of total and antigen-experienced CD4 + T cells in the lung dLNs 3 and 5 days after infection (Supplemental Figure 2 , C and D). Considered together, these data argue that a defect in activation and expansion of T cells in the dLNs or spleen was not the cause of the blunted CD4 + T cell response in the lungs of Nlrc4 -/-mice.
Increased T cell death in the lungs of Nlrc4
-/-mice following IAV infection. Given that early DC-dependent events in the development of the IAV-specific CD4 + T cell response appeared to proceed normally in Nlrc4
-/-mice, we assessed whether the decrease [323] [324] [325] [326] [327] [328] [329] [330] [331] [332] [333] [334] [335] [336] [337] [338] [339] . Seven days after infection, the indicated cells were quantified in the lungs. Data are representative of 2 independent experiments (n = 5-6 per group). Error bars represent the SEM. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001, by 2-tailed Student's t test. jci.org Volume 129
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DCs isolated from IAV-infected WT and Nlrc4 -/-mice, which have similar FasL expression levels (Supplemental Figure 5C ). To test whether the increased killing of CD4 + T cells by Nlrc4 -/-DCs was dependent on Fas-FasL interactions, we blocked this interaction by adding Fas-Fc to the cocultures. Addition of Fas-Fc to cocultures increased the survival of IAV-specific lung CD4 + T cells cultured with WT and Nlrc4 -/-lung DCs to a similar degree ( Figure 5A ) but had no effect on CD4 + T cells cultured alone (Supplemental Figure  5D ), indicating that DC FasL is responsible for killing CD4 + T cells. Consistent with the finding that CD8 + T cell numbers in the lungs of IAV-infected mice were not significantly diminished in the absence of NLRC4 (Figure 2, E and F Figure 6A) . Although 40% of the WT mice that received WT BMDCs survived to post-infection day 14, the WT mice that received Nlrc4 -/-BMDCs had significantly greater mortality rates ( Figure 5C ). On day 7 after infection, we enumerated pulmonary CD4 + and CD8 + T cells for a subset of infected WT mice that received WT or Nlrc4 -/-BMDCs. We observed a marked loss of total and IAV-specific CD4 + T cells in the WT hosts that received Nlrc4 -/-mice 7 days after infection ( Figure 4B and Supplemental Figure 5A ). We also found no difference in the proportion of Fas + IAV-specific CD4 + T cells in the lungs of WT or Nlrc4 -/-mice, in agreement with the data indicating a T cell-extrinsic cause of death (Supplemental Figure 5B) .
To determine whether DCs from IAV-infected Nlrc4 -/-lungs were killing CD4 + or CD8 + T cells, we modified a previously described DC-T cell coculture assay (15 Figure 5A ). Additionally, we observed no difference in lung CD4 + T cell survival following coculture with splenic + DCs were enumerated by flow cytometry for the indicated organ and time point after infection (A) or in the lung on day 7 after infection (B). Data are from 1 experiment (A, day 5, and B, n = 3-5 per group) or 2 separate experiments (A, day 7, n = 9-10 per group). Error bars show the SEM. **P < 0.01 and ***P < 0.001, by 2-tailed Student's t test. jci.org Volume 129 Number 7 July 2019 its translocation to the nucleus and preventing it from activating its target genes (40) . We observed that BMDCs from Nlrc4 -/-mice had diminished Akt1 and FoxO3a phosphorylation compared with WT BMDCs (Figure 6 , B and C), suggesting that NLRC4 may regulate FasL expression through Akt1 and FoxO3a phosphorylation.
Discussion
The data presented here show for the first time to our knowledge that Nlrc4 -/-mice have a defective immune response during IAV infection. Nlrc4 -/-mice show increased morbidity and mortality and impaired viral clearance, but these do not appear to be the result of a defect in cytokine/chemokine production or the innate immune response. Instead, we report a blunted IAV-specific CD4 + T cell response in the lungs of Nlrc4 -/-mice. The number of pulmonary IAV-specific CD4 + T cells was dramatically decreased, but CD8 + T cells were largely unaffected. Ultimately, the loss of IAV-specific CD4 + T cells in Nlrc4 -/-mice was a result of increased CD4 + T cell death due to Fas-FasLmediated killing by CD11b lo and CD11b -DCs in the lungs. The increased susceptibility of Nlrc4 -/-mice to IAV infection appears to be NLRC4 inflammasome independent, as we observed no changes in the inflammasome-dependent cytokine IL-1β or caspase-1 cleavage in Nlrc4 -/-lungs during infection. The NLRP3 and AIM2 inflammasomes are activated during IAV infection (21, 22, 41) , thus the caspase-1 activation and IL-1β secretion we observed are expected, given the activity of those inflammasomes. Interestingly, the level of IL-1β was slightly, but not significantly, increased in Nlrc4 -/-lungs, as determined by ELISA. This result may indicate increased activation of the NLRP3 or AIM2 inflammasomes, which could be due to the elevated viral titers and therefore more abundant activating signals in Nlrc4 -/-mice. Previous studies focused on the NLRP3 inflammasome showed no effect of NLRC4 deficiency on morbidity or mortality following IAV infection (21, 22) . We find these data intriguing in light of the very clear survival defect in Nlrc4 -/-mice we report here. The reason for the differences in these studies is probably multifactorial. When we infected mice with a lower inoculum of IAV, we no longer observed an increase in mortality among the Nlrc4 -/-mice compared with WT mice, however the Asc -/-mice were more susceptible, even at this lower inoculum, consistent with previously published findings ( Figure 1D) (21, 22) . Additionally, since those studies were published, we have developed an increased appreciation for the impact that genetic background has on knockout mice. We postulate that differences in the WT sub- strains used as controls and for backcrossing with Nlrc4 -/-mice may further contribute to the discrepancy between the results presented here and previous reports. Of particular note, we and others have recently shown differences between C57BL/6J and C57BL/6N substrains in survival and inflammatory responses to IAV (31, 42) . We and others have also reported striking differences in immune responses to additional inflammatory challenges among C57BL/6 substrains (42) (43) (44) . In the present study, we rigorously tested the specificity of our phenotype to a loss of NLRC4 through the use of littermate controls and by confirmation in an independently generated Nlrc4 -/-mouse (Supplemental Figure 2 , E and F, and Supplemental Figure 6 , F and G).
NLRC4 was recently reported by our laboratory to have an inflammasome-independent role in limiting melanoma progression (20) . Although IAV infection and melanoma are considerably different challenges for the host immune system, in both cases, a robust host T cell response is a correlate of protection. During both IAV infection and melanoma challenge, Nlrc4 -/-mice exhibit defective T cell responses, and in both models, myeloid cell dysfunction seems to be driving the defect (20) . Intriguingly, it was recently shown that FASLG is highly expressed in a large number of human cancers and that engineering tumor-specific T cells to resist Fasmediated death is a promising strategy for enhancing immunotherapy during cancer (45) . It would be of interest to determine whether there is NLRC4-mediated modulation of myeloid cell FasL during melanoma progression and whether the ineffective melanoma-specific T cell responses observed in Nlrc4 -/-mice could be rescued by disrupting Fas-FasL interactions or downstream signaling.
An important remaining question to answer is how NLRC4 is acting in these myeloid cells to influence FasL expression. Offering a single explanation that accounts for all of the observations is challenging because of the dynamic nature of immune responses and their regulatory mechanisms, but we speculate that NLRC4 may be involved in differentiation or activation of myeloid cells during an inflammatory insult. That unstimulated Nlrc4 -/-BMDCs, but not Casp1/11 -/-or Asc -/-BMDCs, have increased FasL mRNA and protein levels is suggestive of an inflammasome-independent function of NLRC4 in either the development and/or differentiation of DCs. Fasl gene expression is controlled by a number of distinct transcription factor interactions at the Fasl promoter (46) . FoxO3a can be phosphorylated by Akt1, resulting in its inactivation as a transcription factor. Conversely, dephosphorylation of FoxO3a results in upregulation of FasL and triggers increased apoptosis (40) . In the absence of NLRC4, we observed diminished Akt1 and FoxO3a phosphorylation, which may have been driving increased FasL expression. As many signaling pathways involved in metabolism, cytokine sensing, and pathogen-associated molecular pattern (PAMP) and damage-associated molecular pattern (DAMP) sensing converge on Akt (47), it is possible that dysregulated activating signals in the absence of NLRC4 result in increased FasL expression.
In conclusion, the work described here demonstrates a protective role for NLRC4 during IAV infection. Protection is probably NLRC4 inflammasome independent and involved support of the IAV-specific CD4 + T cell response in IAV-infected lungs. In the absence of NLRC4, expression of FasL on CD11b lo and CD11b -lung DCs was increased, triggering more CD4 + T cell death in the lungs of IAV-infected animals and the associated increased mortality. These findings are of importance, as they expand our understanding of how the IAV-specific CD4 + T cell response in the lungs is regulated and implicate DC NLRC4 in the regulation of CD4 + T cell responses.
Methods
Mice. The generation of Nlrc4
, and Casp1/11 -/-mice has been described elsewhere (48) (49) (50) . Mice were backcrossed with C57BL/6N mice for at least 10 generations and maintained in a specific pathogen-free (SPF) facility. C57BL/6N mice were purchased from Charles River Laboratories and used as WT controls unless otherwise stated; B6.Cg-Tg(TcraTcrb)425Cbn/J (OT-II CD90.2 + ) mice were purchased from The Jackson Laboratory. Femurs from Nlrc4 -/-mice (39) were a gift from Matam Vijay-Kumar (University of Toledo, Toledo, Ohio, USA). Both male and female mice (6-12 weeks of age) were used, however, mice were sex, age, and weight matched for individual experiments. Virus and in vivo infection. The mouse-adapted IAV strain A/ PR/8/34 (PR/8) was propagated as previously described (16) . Recombinant IAV-OT-II was created using standard reverse genetics as previously described (51) and grown in 10-day-old embryonated chicken eggs (Charles River Laboratories). The OT-II epitope (Ova 323-339 ) was ) alone per well of a 96-well plate were incubated in Iscove's DMEM (Gibco, Thermo Fisher Scientific) containing 10% HI-FCS (Atlanta Biologicals), 1× β-mercaptoethanol (Gibco, Thermo Fisher Scientific), 1× penicillin-streptomycin (Gibco, Thermo Fisher Scientific), 1× l-glutamine (Gibco, Thermo Fisher Scientific), and 1× sodium pyruvate (Gibco, Thermo Fisher Scientific). For some experiments, 2.5 μg/ml Fas-Fc (R&D Systems) was included. Cells were incubated for 12 hours at 37°C and 5% CO 2 and then assessed by flow cytometry, as above.
Isolation Western blotting. Lysates were prepared in RIPA buffer (Cell Signaling Technology) with 1 mM PMSF according to the manufacturer's instructions. Lungs were homogenized in RIPA buffer using a Tissue-Tearor (BioSpec Products). A bicinchoninic acid (BCA) assay (Thermo Fisher Scientific) was performed to measure total protein in lung homogenates, and then samples were diluted to the same concentration in RIPA buffer. Lysates were stored at -80°C. Proteins were separated on a NuPAGE gel (Invitrogen, Thermo Fisher Scientific) and transferred onto a PVDF membrane using the XCell II blotting system (Invitrogen, Thermo Fisher Scientific). Membranes were blocked with 5% nonfat milk or BSA and incubated with anti-caspase-1 (p20) antibody ( Real-time PCR. Total RNA was isolated from BMDCs using a RNeasy Mini Kit (QIAGEN), and cDNA was generated with PrimeScript RT Master Mix (Takara Bio) according to the manufacturer's instructions. Real-time PCR was carried out using the CFX Real-Time PCR System (Bio-Rad) with a SYBR Green molecular probe (Applied Biosystems). mRNA levels were quantitatively analyzed using Bio-Rad CFX Manager 3.1 software. Relative mRNA expression levels were normalized to the housekeeping gene Actb. The primers used were: FasL, forward, 5′-CCTGTGTCACCACTACCACC-3′, reverse, 5′-CCACCG-GTAGCCACAGATTT-3′; β-actin, forward, 5′-CGAGGTATCCTGAC-CCTGAA-3′, reverse, 5′-GGTGTGGTGCCAGATCTTCT-3′.
DC adoptive transfer. BMDCs were differentiated as previously described (54) . BMDCs were analyzed by flow cytometry and/or 5 × 10 5 BMDCs in 50 μl sterile DMEM were administered intranasally to IAV-infected mice 5 days after infection. Statistics. Statistical tests used to determine significance are indicated in the figure legends. Error bars represent the mean ± SEM. Statistical significance was based on the Mantel-Cox test for Figure 1 , A and D, and Figure 5C ; 1-way ANOVA with Tukey's post hoc analysis for Figure 1B ; and a 2-tailed Student's t test for all remaining data. P values of 0.05 or less were considered statistically significant. Data were graphed and statistical tests performed using GraphPad Prism (GraphPad Software).
inserted into the mRNA nucleotide position 186 encoding the neuraminidase stalk region, which is known to tolerate such insertions (52) . Mice were anesthetized with ketamine and xylazine and infected intranasally with 0.5 LD 50 virus diluted in 50 μl sterile DMEM. Weight was monitored daily, and the mice were euthanized upon loss of 30% of their starting weight. CFSE labeling of lung cells followed by IAV infection were performed as described previously (36) , but CFSE was administered 15 minutes prior to infection.
Lung titers. To measure virus titers, lungs were homogenized using a Tissue-Tearor (BioSpec), and homogenates were then clarified by centrifugation, snap-frozen in liquid nitrogen, and stored at -80°C. A standard plaque assay on Madin-Darby canine kidney (MDCK) cells was subsequently used to quantify infectious virus (53) .
ELISA. Cytokines and chemokines were quantified in cell culture supernatants and lung homogenate supernatants using DuoSet Mouse ELISA kits from R&D Systems (for CXCL1, CXCL2, CXCL5, CXCL9, CXCL10, IL-1β, CCL2, and CCL5) or ReadySetGo! Mouse ELISA kits from eBioscience (for IL-1α, IL-6, IL-10, and TNF-α) following the manufacturers' instructions.
Flow cytometry. Single-cell suspensions were prepared by pressing tissues through wire mesh screens (lungs) or dissociating between frosted ends of glass slides (spleens and LNs). For some experiments, cells were minced and digested in Iscove's DMEM (Gibco, Thermo Fisher Scientific) containing 1 mg/ml collagenase XI (Millipore Sigma) and 0.02 mg/ml DNase (MilliporeSigma) for 15 minutes at 37°C prior to physical dissociation. 
DC-T cell coculture.
The DC-T cell coculture assay was adapted from a previously described assay (15 Study approval. All animal studies were approved by and performed according to the guidelines of the IACUC of the University of Iowa and Cedars-Sinai Medical Center.
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